Canada markets open in 14 minutes

Nxera Pharma Co., Ltd. (SOLTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
9.300.00 (0.00%)
At close: 12:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 847.11M
Enterprise Value 1.00B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)9.40
Price/Book (mrq)1.95
Enterprise Value/Revenue 0.08
Enterprise Value/EBITDA -0.18

Trading Information

Stock Price History

Beta (5Y Monthly) 0.60
52-Week Change 3-52.96%
S&P500 52-Week Change 323.57%
52 Week High 322.78
52 Week Low 38.56
50-Day Moving Average 310.13
200-Day Moving Average 310.26

Share Statistics

Avg Vol (3 month) 3925
Avg Vol (10 day) 3176
Shares Outstanding 589.45M
Implied Shares Outstanding 691.05M
Float 866.49M
% Held by Insiders 19.63%
% Held by Institutions 141.86%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Mar 27, 2015
Last Split Factor 2100:1
Last Split Date 3Mar 27, 2013

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -56.35%
Operating Margin (ttm)-33.01%

Management Effectiveness

Return on Assets (ttm)-5.07%
Return on Equity (ttm)-11.53%

Income Statement

Revenue (ttm)12.77B
Revenue Per Share (ttm)154.71
Quarterly Revenue Growth (yoy)5.30%
Gross Profit (ttm)N/A
EBITDA -7.92B
Net Income Avi to Common (ttm)-7.19B
Diluted EPS (ttm)-0.56
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)49.38B
Total Cash Per Share (mrq)552.08
Total Debt (mrq)73.97B
Total Debt/Equity (mrq)110.72%
Current Ratio (mrq)3.79
Book Value Per Share (mrq)746.93

Cash Flow Statement

Operating Cash Flow (ttm)-5.27B
Levered Free Cash Flow (ttm)-11.21B